House Committee Watching Genasense; Show Of Force During FDA Review
Executive Summary
The House Energy & Commerce Committee is keeping a close watch on FDA's handling of the application for Aventis/Genta's Genasense
You may also be interested in...
Aventis, Genta To Meet With FDA After Genasense NDA Withdrawal
Aventis will participate in Genta's meeting with FDA following the withdrawal of the new drug application for Genasense
Aventis, Genta To Meet With FDA After Genasense NDA Withdrawal
Aventis will participate in Genta's meeting with FDA following the withdrawal of the new drug application for Genasense
FDA Under Scrutiny: Congress Presses Agency On Antidepressants, Plan B
Congress is asking FDA to document its actions in two high-profile agency decisions